1. Market Research
  2. > Cancer Industry

Leukemia Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, HPV Testing, Therapy, Infectious Disease, Hematology Instrument, Hospital, Cancer Diagnostic, Pharmaceutical, Transplantation, Blood Disease, Blood Supply, Cell Therapy, Lymphoma, Medical Equipment, Vaccine, Biopharmaceutical, Stem Cell, Veterinary Drug.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Global Biopharmaceuticals Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the yea ...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2017

  • $ 2000
  • Company report
  • August 2017
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline ...

Erytech Pharma SA (ERYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2017
  • by GlobalData

Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that offers development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product ...

GlycoMimetics Inc (GLYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2017
  • by GlobalData

Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), ...

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) – Pipeline Review, H2

  • $ 3500
  • Company report
  • August 2017
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Recepto ...

Pharmacyclics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s ...

MacroGenics Inc (MGNX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, ...

Celator Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine ...

Cyclacel Pharmaceuticals Inc (CYCC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control fo ...

Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Hybrigenics SA (Hybrigenics) offers research and development of new targets and therapies against proliferative cancerous or non-cancerous diseases. Its lead product candidate is inecalcitol, which ...

About 5900 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Leukemia Statistics in the US

  • January 2016
    147 pages
  • Leukemia  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.